亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Single-Cell Profiling Explore the Immunologic Mechanisms of Tumor Relapse in Hepatocellular Carcinoma

作者
Liyi Zhang
出处
期刊:Global medical genetics [Georg Thieme Verlag]
卷期号:08 (03): 083-084
标识
DOI:10.1055/s-0041-1729545
摘要

Despite the worldwide decrease in liver cancer incidence and mortality over the past decade, it is still the fourth leading cause of cancer-related death.[ 1 ] The burden of liver cancer is still serious, especially in China.[ 2 ] In 2018, more than half of the liver cancer cases and deaths occurred in China.[ 3 ] Hepatocellular carcinoma (HCC) is the most common subtype of liver cancer, accounting for 75% of all liver cancer cases.[ 4 ] Surgical resection is the first choice for early-stage HCC, but more than 70% of HCC patients develop recurrent cancer within 5 years after surgery,[ 5 ] which is the major cause of death in long-term evaluations. Among them, nearly 70% relapsed cases develop an early recurrence within 2 years of surgery.[ 5 ] However, the precise molecular mechanisms of rapid recurrence remain unclear. Tumor immune microenvironment (TIME) consists of various immune cells; education of tumor cells has become a hot topic in cancer research due to its association with initiation, progression, and recurrence.[ 6 ] Therefore, profiling the immune contexture of HCC, which is determined by the composition, density, and functional orientation of tumor-infiltrating immune cells, could provide insights into immune escape mechanisms and helpful to design effective therapeutic strategies for recurrent HCC. Single-cell RNA sequencing (scRNA-seq) is the most powerful tool for tumor immune contexture profiling.[ 7 ] With broad implications for both basic and clinical cancer research, scRNA-seq has already impacted our conceptual understanding of cancer progression in several cancer types. Although the immune contexture detected by scRNA-seq in primary HCC has been reported,[ 8 ] that in early-relapse HCC is still unknown. In a study recently published in Cell , titled “Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma,” Sun et al[ 9 ] examined 16,498 single-cell transcriptomes from 12 primary and 6 early-relapse HCC tumor tissues by scRNA-seq to define immune contexture at the single-cell resolution level. They found that early-relapse HCC had a distinctive immune contexture that is different from primary HCC. Compared with primary HCC, the density of regulatory T-cells (Tregs) was decreased and those of dendritic cells (DCs) and infiltrated CD8 + T-cells were increased in early-relapse HCC. Additionally, CD8 + T-cells in primary HCC displayed a classical exhausted state, but those in early-relapse HCC overexpressed CD161 and resided in an innate-like phenotype with low clonal expansion and cytotoxic state. These alterations were associated with a worse prognosis in HCC. The authors further explored the potential mechanisms of immune escape in early-relapse HCC. They found that tumor cells in early-relapse HCC could evade the host immune system's detection and destruction through suppressing DC-mediated antigen presentation and recruiting CD161 high CD8 + T-cells. The high incidence of early recurrence is the main reason for the poor clinical outcomes of HCC. Ignoring the differences between recurrent and primary tumors, recurrent HCCs are often treated based on the pathological characteristics and molecular classification of the primary HCCs. Although previous studies have reported that similar genomic alterations occurred in both primary and early-relapse HCCs,[ 10 ] whether primary and early-relapse HCCs have differences in immune contexture is still unknown. The present study dissected and compared the TIME of primary and early-relapse HCCs by scRNA-seq. Unlike the findings in primary HCC reported in the previous studies (the primary HCC cells recruit Tregs to suppress the immune response[ 8 ]), this study found that Tregs were excluded and CD161 high CD8 + T-cells were recruited to create an immunosuppressive microenvironment in early-relapse HCC. In CD161 high CD8 + T-cells from recurrent tumor tissues, the expression levels of proliferation- and cytotoxicity-associated genes were significantly reduced and tissue residence–associated genes were increased as compared with those in CD8 + T-cells from primary tumor tissues. CD161 is reported to be a surface marker for CD8 + T-cells with innate-like and memory phenotype.[ 11 ] In microbial infection, CD161 high CD8 + T-cells contribute to the early control of microbial recall infections in both antigen-dependent and -independent manners.[ 12 ] Therefore, the adaptive immune response of these cells is considered to be one of the important components of the immune response to the infectious diseases that have ever suffered.[ 13 ] However, regardless of the obvious increase of CD161 high CD8 + T-cell infiltration, HCC early recurrence can be achieved, which indicates that these T-cells cannot prevent the spread of HCC. The following observations of this study reveal why CD161 high CD8 + T-cells with memory phenotypes cannot prevent HCC recurrence: (1) compared with CD161 − CD8 + T-cells, CD161 high CD8 + T-cells had a weaker antitumor ability, which was manifested as a decrease in the production of granzyme B and (2) T-cell receptor analysis indicated that CD161 high CD8 + T-cells in early-relapse HCC reduced clonal expansion and shared most of T-cell receptor clone types with CD8 + T-cells in primary HCC. These findings indicated that CD161 high CD8 + T-cells had the ability to target the clonal neoantigens in primary HCCs, but they could not be effectively activated in early-relapse HCCs. DCs are critical antigen presenting cells. They play a key role in the regulation of the balance between CD8 + T-cell immunity and tolerance to neoantigens. In the present study, enhanced effector functions of CD8 + T-cells were not associated with the increased DC infiltration in early-relapse HCC and suggested that the antigen presentation functions of DCs were impaired in early-relapse HCCs. As we know, CD28 plays a central role in the regulation of T-cell activation and inhibition.[ 14 ] Previous study found that programmed death-ligand 1 (PD-L1) has a stronger affinity for CD80 when compared with CD28.[ 15 ] As early-relapse HCC exhibited more PD-L1 + tumor cells than primary HCC, CD80 on a DC might preferentially bind to PD-L1 on early-relapse HCC cells rather than CD28 on a resting T-cell. Therefore, PD-L1 + recurrence tumor cells may prevent T-cell activation from killing them via reducing CD80–CD28 interactions. If this speculation is true, it means that tumor immunotherapy plus chemotherapy or targeted therapy may be more effective than immune checkpoint blockade as a single agent for patients with recurrent HCC. Overall, this study provided a comprehensive single-cell profiling in early-relapse HCC and explored the immunologic mechanisms of tumor relapse for the first time. It highlighted the potential significance of targeting immune contexture of HCC, and provided a solid foundation for the development of novel therapeutic strategies for recurrent HCC. Author's Contribution The author read and approved the final manuscript. Publication History Article published online: 11 June 2021 © 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
化学新人完成签到,获得积分20
3秒前
科目三的应助被研猫采纳,获得10
3秒前
211JZH完成签到 ,获得积分10
6秒前
哇咔咔完成签到 ,获得积分10
6秒前
8秒前
俭朴紫文完成签到,获得积分10
9秒前
10秒前
良久完成签到 ,获得积分10
10秒前
xl完成签到,获得积分10
13秒前
zrl完成签到,获得积分20
14秒前
15秒前
神勇的筝完成签到,获得积分10
16秒前
王占雪完成签到 ,获得积分10
16秒前
17秒前
王老裂完成签到,获得积分10
18秒前
h11的应助被纯情的阁采纳,获得10
19秒前
h11的应助被纯情的阁采纳,获得10
19秒前
h11的应助被纯情的阁采纳,获得10
20秒前
h11的应助被纯情的阁采纳,获得10
20秒前
h11的应助被纯情的阁采纳,获得10
20秒前
h11的应助被纯情的阁采纳,获得10
20秒前
Monster发布了新的文献求助10
20秒前
年轻牛排完成签到 ,获得积分10
20秒前
奔跑的应助被纯情的阁采纳,获得10
20秒前
h11的应助被纯情的阁采纳,获得10
21秒前
sunflower发布了新的文献求助10
21秒前
25秒前
迷路万天完成签到,获得积分10
28秒前
Jasper的应助被研猫采纳,获得10
29秒前
30秒前
31秒前
wshwx完成签到,获得积分10
31秒前
32秒前
32秒前
张日国完成签到,获得积分10
32秒前
传奇3的应助被染8采纳,获得10
33秒前
SCI完成签到,获得积分10
35秒前
36秒前
强健的梦秋完成签到,获得积分10
37秒前
39秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158582
求助须知:如何正确求助?哪些是违规求助? 9554358
关于积分的说明 21719049
捐赠科研通 7748110
什么是DOI,文献DOI怎么找? 3427032
关于科研通互助平台的介绍 2551881
邀请新用户注册赠送积分活动 2471262